ALTERI, CLAUDIA

ALTERI, CLAUDIA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 79 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 1-lug-2016 C. AlteriC. F. PernoA. Lazzarin + Article (author) -
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 1-gen-2021 Alteri, Claudia + Article (author) -
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy 1-gen-2019 Alteri C.Perno C. F. + Article (author) -
Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria 1-set-2008 ALTERI CPERNO CF + Article (author) -
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs 16-lug-2009 ALTERI CPERNO CF + Article (author) -
Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02-AG) in Italy 1-gen-2012 Alteri C.Perno C. F. + Article (author) -
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains 1-gen-2017 C. AlteriC. F. Perno + Article (author) -
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 1-ago-2018 Perno C. F.Alteri C. + Article (author) -
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes 18-gen-2013 Alteri CPerno CF + Article (author) -
Detecting and understanding genetic and structural features in HIV-1 B subtype V3 underlying HIV-1 co-receptor usage 15-feb-2013 Alteri CPerno CF + Article (author) -
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients 1-gen-2020 Alteri C.Cento V.Antonello M.Colagrossi L.Renica S.Tartaglione L.Costabile V.Perno C. F. + Article (author) -
Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000) 1-gen-2022 Alteri, Claudia + Article (author) -
Different Evolution of Genotypic Resistance Profiles to Emtricitabine Versus Lamivudine in Tenofovir-Containing Regimens 1-gen-2010 Alteri CPerno CF + Article (author) -
Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine 9-dic-2011 Alteri CPerno CF + Article (author) -
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 1-ott-2017 C. AlteriD. Di CarloC. Perno + Article (author) -
Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child 1-gen-2016 C. AlteriC. F. Perno + Article (author) -
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029 1-gen-2015 Alteri CPerno CF + Article (author) -
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy 1-gen-2020 Cento V.Alteri C.Tartaglione L.Nava A.Colagrossi L.Ughi N.Scaglione F.Perno C. F. + Article (author) -
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages 28-set-2017 Alteri CPerno CF + Article (author) -
Epidemiological characterization of SARS-CoV-2 variants in children over the four COVID-19 waves and correlation with clinical presentation 17-giu-2022 Alteri, ClaudiaScutari, Rossana + Article (author) -